contractor articles (684)
Active Articles:
A52725: Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and NeuropathyA52754: Non-Payment for Prefabricated Splints
A52755: Billing and Coding: Outpatient Therapy Biofeedback Training
A52759: Therapy Driving Evaluations
A52773: Billing and Coding: Therapy Evaluation, Re-Evaluation and Formal Testing
A52775: Billing and Coding: Medical Necessity of Therapy Services
A52926: Sipuleucel-T (Provenge®) - Coverage Criteria for Prostate Cancer – Clarification
A53009: Billing and Coding: Intraocular Bevacizumab
A53028: Billing and Coding: Bariatric Surgery Coverage
A53033: Self-Administered Drug Exclusion List:
A53046: Billing and Coding: Wound Care and Debridement - Provided by a Therapist, Physician, NPP, or as Incident-to Services
A53975: Billing and Coding: Spinal Fusion Services: Documentation Requirements
A54063: Billing and Coding: Arthroscopic Lavage and Arthroscopic Debridement for Osteoarthritic Knees
A54388: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A54424: Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54553: Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)
A54591: Response to Comments: MolDX: Prolaris Prostate Cancer Genomic Assay, L36349
A54596: Response to Comments: Special Histochemical Stains and Immunohistochemical Stains, L36352
A54632: Response to Comments: MolDX: Decipher Prostate Cancer Classifier Assay
A54646: Response to Comments: Immune Globulin Intravenous (IVIg)
A54714: Response to Comments: Treatment of Varicose Veins of Lower Extremities
A54894: Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia
A54896: Response to Comments: MolDX: MGMT Promoter Methylation Analysis
A54916: Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A54931: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers – Coding and Billing
A54965: Response to Comments: MolDX: Genetic Testing for Lynch Syndrome
A54979: Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment
A54981: Response to Comments: Spinal Cord Stimulators for Chronic Pain
A54991: Response to Comments: Nerve Conduction Studies and Electromyography
A54992: Billing and Coding: Nerve Conduction Studies and Electromyography
A55029: Billing and Coding: Lab: Bladder/Urothelial Tumor Markers
A55030: Billing and Coding: Urine Drug Testing
A55031: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014.
A55034: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A55045: Billing and Coding: Patients Supplied Donated or Free-of-Charge Drug
A55049: Response to Comments: MolDX: NRAS Genetic Testing
A55055: Response to Comments: Treatment of Males with Low Testosterone
A55076: Response to Comments: Total Hip Arthroplasty
A55077: Response to Comments: Total Knee Arthroplasty
A55155: Response to Comments: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A55295: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
A55323: Billing and Coding: Implantable Infusion Pumps for Chronic Pain
A55362: Response to Comments: Serum Magnesium
A55373: Response to Comments: Vitamin D Assay Testing
A55384: Response to Comments: Botulinum Toxin Types A and B
A55458: Response to Comments: Bladder/Urothelial Tumor Markers
A55471: Response to Comments: MolDX- CDD: ProMark Risk Score
A55473: Response to Comments: Trigger Point Injections
A55490: Response to Comments: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
A55492: Response to Comments: Polysomnography and Other Sleep Studies
A55528: Response to Comments: GlycoMark Testing for Glycemic Control
A55531: Billing and Coding: Peripheral Nerve Stimulation
A55554: Response to Comments: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A55558: Response to Comments: Diagnostic and Therapeutic Colonoscopy
A55600: Billing and Coding: MolDX: BCR-ABL
A55602: Billing and Coding: MolDX: PIK3CA Gene Tests
A55659: Response to Comments: MolDX DecisionDX Uveal Melanoma
A55662: Response to Comments: MolDX: Xpresys Lung
A55685: Response to Comments: Plastic Surgery
A55689: Response to Comments: Cataract Surgery in Adults
A55756: Billing and Coding: Home PT/INR Monitoring (G0249) Billing and Coding
A55779: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55794: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A55904: Response to Comments: Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder
A55932: Billing and Coding: JW and JZ Modifier Billing Guidelines
A55938: Response to Comments: Chest X-Ray Policy
A55988: Response to Comments: Respiratory Care (Respiratory Therapy)
A56018: Response to Comments: Lumbar MRI
A56026: Billing and Coding: Topical HBO and Physician Related Service Billing and Coding Guidelines
A56042: Response to Comments: Peripheral Nerve Stimulation
A56067: Response to Comments: MRI and CT Scans of Head and Neck
A56073: Billing and Coding: In Vitro Chemosensitivity & Chemoresistance Assays
A56077: Response to Comments: In Vitro Chemosensitivity & Chemoresistance Assays
A56104: Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors
A56213: Response to Comments: MolDX: Cystatin C Measurement
A56231: Response to Comments: MolDX: DecisionDx-Melanoma
A56241: Response to Comments: Frequency of Hemodialysis
A56254: Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A56257: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56342: Billing and Coding: Implantable Automatic Defibrillators
A56357: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56372: Billing and Coding: MolDX: Oncotype DX® Genomic Prostate Score
A56376: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56382: Response to Comments: Helicobacter Pylori Infection Testing
A56410: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56447: Response to Comments: MolDX: MDS FISH
A56515: Billing and Coding: Mohs Micrographic Surgery
A56518: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Testing in Cancer
A57162: Billing and Coding: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A57184: Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A57186: Billing and Coding: Botulinum Toxin Types A and B
A57196: Billing and Coding: Cataract Surgery in Adults
A57198: Billing and Coding: Serum Magnesium
A57207: Billing and Coding: Lumbar MRI
A57215: Billing and Coding: MRI and CT Scans of the Head and Neck
A57225: Billing and Coding: Respiratory Care
A57236: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A57327: Billing and Coding: Electrocardiograms
A57332: Billing and Coding: MolDX: Repeat Germline Testing
A57343: Billing and Coding: Diagnostic and Therapeutic Colonoscopy
A57364: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A57376: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57385: Billing and Coding: MolDX: Pharmacogenomics Testing
A57420: Billing and Coding: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
A57422: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57424: Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A57433: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A57465: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A57487: Billing and Coding: MolDX: NRAS Genetic Testing
A57517: Billing and Coding: MolDX: Prometheus® IBD sgi Diagnostic® Policy
A57527: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A57608: Billing and Coding: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A57609: Billing and Coding: ProMark® Risk Score
A57614: Billing and Coding: Lab: Special Histochemical Stains and Immunohistochemical Stains
A57620: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A57644: Billing and Coding: Lab: Cystatin C Measurement
A57693: Billing and Coding: Transcranial Magnetic Stimulation (TMS)
A57707: Billing and Coding: Treatment of Varicose Veins of the Lower Extremities
A57719: Billing and Coding: Vitamin D Assay Testing
A57792: Billing and Coding: Spinal Cord Stimulators for Chronic Pain
A57797: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A57820: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A57843: Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A57849: Billing and Coding: Tomosynthesis-Guided Breast Biopsy
A57892: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57905: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57906: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57908: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A57909: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57947: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57957: Billing and Coding: Routine Foot Care
A58053: Billing and Coding: MolDX: Pigmented Lesion Assay
A58073: Response to Comments: MolDX Pigmented Lesion Assay
A58097: Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A58138: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58170: Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58177: Response to Comments: MolDX: Repeat Germline Testing
A58187: Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58225: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58229: Billing and Coding: Transurethral Waterjet Ablation of the Prostate
A58238: Response to Comments: MolDX: Pharmacogenomics Testing
A58272: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58399: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58405: Billing and Coding: Facet Joint Interventions for Pain Management
A58456: Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58506: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58508: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58511: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58521: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58523: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A58535: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A58567: Billing and Coding: Wound and Ulcer Care
A58598: Response to Comments: Colon Capsule Endoscopy (CCE)
A58635: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease
A58640: Response to Comments: Facet Joint Interventions for Pain Management
A58670: Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A58674: MolDX: Algorithm definition as a component of a laboratory test
A58681: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58724: Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58749: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58780: Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58782: Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58786: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A58867: Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A58887: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A58904: Response to Comments: Wound and Ulcer Care
A58947: Response to Comments: Colon Capsule Endoscopy (CCE)
A58954: Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer
A58967: Response to Comments: Platelet Rich Plasma Injections for Non-Wound Injections
A58975: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A58995: Billing and Coding: Epidural Steroid Injections for Pain Management
A58997: Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
A59018: Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A59115: Response to Comments: Epidural Steroid Procedures Injections for Pain Management
A59131: Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A59135: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A59144: Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A59155: Response to Comments: Nerve Blockade for Treatment of Chronic Pain and Neuropathy
A59177: Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
A59212: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A59246: Billing and Coding: Sacroiliac Joint Injections and Procedures
A59279: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A59326: Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s and Non-Hodgkin’s Lymphoma with B-Cell or T-Cell Origin
A59334: Response to Comments: Sacroiliac Joint Injections and Procedures
A59354: Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59401: Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59414: Response to Comments: Cataract Surgery In Adults
A59420: Response to Comments: Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
A59441: Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
A59444: Response to Comments: Transcranial Magnetic Stimulation (TMS)
A59453: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A59460: Response to Comments: Urine Drug Testing
A59468: Billing and Coding: Intraosseous Basivertebral Nerve Ablation
A59507: Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59511: Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59515: Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59522: Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59524: Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59532: Response to Comments: Respiratory Care
A59542: Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A59597: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A59599: Response to Comments: Intraosseous Basivertebral Nerve Ablation
A59616: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A59642: Billing and Coding: MolDX: Proteomics Testing
A59645: Billing and Coding: Cervical Fusion
A59652: Response to Comments: Trigger Point Injections (TPI)
A59658: Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices
A59687: MolDX: Defining panel services in MolDX
A59744: MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services
A59748: Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59753: Billing and Coding: Cryoneurolysis Instructions
A59795: Response to Comments: Facet Joint Interventions for Pain Management
A59797: Response to Comments: Cervical Fusion
A59831: Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59853: Response to Comments: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59855: Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59897: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
Retired Articles:
A46154: Standing OrdersA47187: Hyperbaric Oxygen and E/M codes
A47198: Therapy Billing of Time-Based Codes
A47206: High Compression Bandage System Clarification
A47253: Vestibular Rehabilitation
A47257: Leading the Coder: Coverage and Coding Guidelines
A47265: Coverage of Foot Care Services
A47280: Therapy Driving Evaluations
A47315: Local Coverage Determination (LCD) Notification Process: Draft to Active Status
A47372: Investigational Device Exemptions (IDE's)
A47935: Extracorporeal Photopheresis-NCD 110.4
A48122: NMES and FES Services
A48780: Outpatient Therapy Biofeedback Training
A48817: Humanitarian Use Devices and Exemptions (HUDs and HDEs)
A49206: Incident To Clarification for OPPS and CAH Outpatient
A50299: Clostridium Histolyticum (Xiaflex™) Coverage and Billing R3
A50366: Rural Air Ambulance Service Protocols
A51259: E/M Services and Drug Administration Billing
A51785: Bariatric Surgery Coverage
A51874: Self-Administered Drug Exclusion List R8
A52028: Wound Care and Debridement – Provided by Physician, NPP, or as Incident-to Services
A52082: CPT Category III Non Covered and Covered Codes
A52483: Injectable Bulking Agents for the Treatment of Fecal Incontinence
A52563: Changes in Noridian’s List of Drugs that are Usually Self Administered - R1
A52655: Hyperthermia Therapy for Cancer Treatment
A52731: Hemodialysis Access Examination (CPT 93990)
A52733: Implantable Miniature Telescope
A52752: High Compression Bandage System Clarification
A52753: Maintenance Programs
A52760: Therapy Evaluation and Assessment Services
A52762: Medical Necessity of Therapy Services
A52763: Therapy Students and Aides
A52766: Wound Care and Debridement – Provided by Physician, NPP, or as Incident-to Services
A52769: Ocular Photodynamic Therapy (OPT) with Verteporfin
A52815: Retirement of Jurisdiction F Local Coverage Determinations L24273 (Part B) and L24409 (Part A), Application of Bioengineered Skin Substitutes: Ulcers of the Lower Extremities
A52950: Billing and Coding: Treatment with Yttrium-90 Microspheres
A52967: Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices
A53010: Intraocular Bevacizumab Coding/Billing Guidelines
A53140: Medical Nutrition Therapy
A53180: Testopel™ Coverage
A53346: Outpatient Therapy Biofeedback Training
A53826: HemoDialysis Frequency
A53959: High Resolution Anoscopy
A54070: Billing and Coding: Outpatient Cardiac Rehabilitation
A54357: MolDX: Afirma™ Assay by Veracyte Billing and Coding Guidelines
A54358: Billing and Coding: MolDX: Afirma™ Assay by Veracyte
A54365: MolDX: AlloMap Billing and Coding Guidelines
A54377: MolDX: Avise PG Assay Billing and Coding Guidelines
A54387: MolDX: bioTheranostics Cancer TYPE ID® Billing and Coding Guidelines
A54430: MolDX: Corus® CAD Test Billing and Coding Guidelines
A54439: Billing and Coding: MolDX: HERmark® Assay by Monogram
A54481: MolDX: Oncotype DX® Breast Cancer Assay Billing and Coding Guidelines
A54485: MolDX: Oncotype DX® Colon Cancer Coding and Billing Guidelines
A54496: Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A54501: MolDX: FDA-Approved KRAS Tests
A54504: MolDX: Vectra™ DA Bill and Coding Guidelines
A54505: Billing and Coding: MolDX: Vectra™ DA
A54544: Therapeutic Apheresis for Familial Hypercholesterolemia
A54668: Billing and Coding: Positron Emission Tomography Scans Coverage
A55178: Billing and Coding: MolDX: CYP2B6 Test
A55180: Billing and Coding: MolDX: CYP2C9 and/or VKORC1 Gene Testing for Warfarin Response
A55182: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A55184: Billing and Coding: MolDX: FANCC Genetic Testing
A55186: MolDX: FDA Approved ALK Companion Diagnostic Tests Billing and Coding Guidelines
A55256: Billing and Coding: MolDX: HEXA Gene Analysis
A55275: Billing and Coding: MolDX: Know error®
A55278: Billing and Coding: MolDX: L1CAM Gene Sequencing
A55284: Billing and Coding: MolDX: MCOLN1 Genetic Testing
A55286: Billing and Coding: MolDX: MECP2 Genetic Testing
A55293: Billing and Coding: MolDX: myPap™
A55447: Pegfilgrastim (Neulasta) J2505 and Q5122 - (Injection, pegfilgrastim-apgf, biosimilar, (Nyvepria))
A55483: Billing and Coding: MolDX: UGT1A1 Gene Analysis
A55598: Billing and Coding: MolDX: OncoCee™
A55613: Billing and Coding: MolDX: IKBKAP Genetic Testing
A55629: MolDX: Next Generation Sequencing Billing and Coding Guidelines
A55631: Billing and Coding: MolDX: SMPD1 Genetic Testing
A55681: Additional Information Required for Coverage and Pricing for Category III CPT® Codes
A55888: Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A56711: Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A57203: Billing and Coding: Lumbar Epidural Injections
A57337: Billing and Coding: 4Kscore® Assay
A57340: Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A57353: Billing and Coding: MolDX: APC and MUTYH Gene Testing
A57355: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A57416: Billing and Coding: MolDX: Corus® CAD Assay
A57460: Billing and Coding: Treatment of Ulcers & Symptomatic Hyperkeratoses
A57511: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay
A57646: Billing and Coding: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
A57691: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A58146: Billing and Coding: Mometasone Furoate Sinus Implant (Sinuva, Propel family of Implants)
A58914: Billing and Coding: Remote Imaging of the Retina to Screen for Retinal Diseases
A59166: Response to Comments: Lumbar Epidural Injections